subscribeSubscribe
Enforcement Report - Week of May 24, 2023

Enforcement Report - Week of May 24, 2023
FDA
24 May 2023
Share Share
Innoviva Specialty Therapeutics Announces FDA Approval for XACDURO

Innoviva Specialty Therapeutics Announces FDA Approval for XACDURO
BUSINESSWIRE
23 May 2023
Share Share
Pfizer halts 4 antibiotics in India due to production issues

Pfizer halts 4 antibiotics in India due to production issues
Joseph Keenan FIERCE PHARMA
19 May 2023
Share Share
Results from Phase 3 ATTACK Trial Published in The Lancet Infectious Diseases

Results from Phase 3 ATTACK Trial Published in The Lancet Infectious Diseases
BUSINESSWIRE
11 May 2023
Share Share
FDA panel backs Innoviva`s drug for multidrug-resistant bacterial infections

FDA panel backs Innoviva`s drug for multidrug-resistant bacterial infections
REUTERS
18 Apr 2023
Share Share
Sulbactam-Durlobactam Unanimously Recommended for Approval by FDA

Sulbactam-Durlobactam Unanimously Recommended for Approval by FDA
BUSINESSWIRE
17 Apr 2023
Share Share
Enforcement Report - Week of February 22, 2023

Enforcement Report - Week of February 22, 2023
FDA
22 Feb 2023
Share Share
Innoviva Announces FDA Acceptance and Priority Review of NDA for (SUL-DUR)

Innoviva Announces FDA Acceptance and Priority Review of NDA for (SUL-DUR)
BUSINESSWIRE
30 Nov 2022
Share Share
Piramal Critical Care Launches First to Market Generic Zinc Sulfate Injection in the U.S.

Piramal Critical Care Launches First to Market Generic Zinc Sulfate Injection in the U.S.
PRNEWSWIRE
19 Aug 2022
Share Share
Entasis Presents Data on Sulbactam-Durlobactam & ETX0462 at 2022 ASM

Entasis Presents Data on Sulbactam-Durlobactam & ETX0462 at 2022 ASM
GLOBENEWSWIRE
09 Jun 2022
Share Share